Magda W. Samaha
About
In The Last Decade
Magda W. Samaha
24 papers receiving 800 citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Pharmaceutical Science 358
- Pulmonary and Respiratory Medicine 209
- Molecular Biology 193
- Biomaterials 175
- Biomedical Engineering 136
Countries citing papers authored by Magda W. Samaha
This map shows the geographic impact of Magda W. Samaha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda W. Samaha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda W. Samaha more than expected).
Fields of papers citing papers by Magda W. Samaha
This network shows the impact of papers produced by Magda W. Samaha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda W. Samaha. The network helps show where Magda W. Samaha may publish in the future.
Co-authorship network of co-authors of Magda W. Samaha
This figure shows the co-authorship network connecting the top 25 collaborators of Magda W. Samaha. A scholar is included among the top collaborators of Magda W. Samaha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magda W. Samaha. Magda W. Samaha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 33 | |
| 3 | 74 | |
| 4 | 1 | |
| 5 | 42 | |
| 6 | Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates breakdown → | 301 |
| 7 | 21 | |
| 8 | 26 | |
| 9 | 12 | |
| 10 | 11 | |
| 11 | 40 | |
| 12 | 61 | |
| 13 | 64 | |
| 14 | 13 | |
| 15 | 3 | |
| 16 | 29 | |
| 17 | 6 | |
| 18 | 1 | |
| 19 | 34 | |
| 20 | [The influence of caffeine on the analgesic effects of salicylamide]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.